{"lastClose": 5.489999771118164, "len": 1115, "date": "2023-03-17", "alpha_1": -0.33909676789534626, "beta_1": 1.5874544481434059, "drawup_1": 1.5486725887776869, "natr_1": 15.442294810872149, "sup_1": -0.25136609363982026, "res_1": 0.48633886093876055, "bullPattern_1": [], "bearPattern_1": ["SHORTLINE"], "rsi_1": 24.796740836510228, "adx_1": 35.90632288933327, "drawdown_1": -0.6822916925367372, "stratHoldSharpe_1": -0.2935707376207533, "stratHoldAlpha_1": 250.79951168549636, "stratHoldDrawdown_1": -0.6449672030997544, "alpha_3mo": -0.17591568251048162, "beta_3mo": 1.6269885885715059, "drawup_3mo": 0.4608541290620036, "natr_3mo": 15.442294810872149, "sup_3mo": -0.061930755714257976, "res_3mo": 0.17486343116862577, "bullPattern_3mo": ["DOJI", "HIGHWAVE", "LONGLEGGEDDOJI", "RICKSHAWMAN", "SPINNINGTOP"], "bearPattern_3mo": [], "rsi_3mo": 14.999988079069151, "adx_3mo": 8.90745178882443, "drawdown_3mo": -0.33130331965780635, "stratHoldSharpe_3mo": -0.6212762297015942, "stratHoldAlpha_3mo": 250.63881351109478, "stratHoldDrawdown_3mo": -0.3052749998780999, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Sector": "Health Care", "IPO Year": 2018.0, "Name": "Allogene Therapeutics Inc.", "Country": "United States", "Market Cap": 791713745, "alpha%_1": 0.17474601004426482, "beta%_1": 0.8928452799818221, "drawup%_1": 0.9976733778752461, "natr%_1": 0.9999898973620653, "drawdown%_1": 0.05999811831228552, "stratHoldSharpe%_1": 0.4020277449824284, "stratHoldAlpha%_1": 0.2676930520881584, "stratHoldDrawdown%_1": 0.04598268136494572, "alpha%_3mo": 0.2959426457013262, "beta%_3mo": 0.8593187719164368, "drawup%_3mo": 0.9009863681241336, "natr%_3mo": 0.9999880849686464, "drawdown%_3mo": 0.08892241733541023, "stratHoldSharpe%_3mo": 0.3086611095138748, "stratHoldAlpha%_3mo": 0.24129083719261474, "stratHoldDrawdown%_3mo": 0.08660599621476345}